Patent Yard Sign in
Canadian application, no grantCanada

Phosphodiesterase 8a

CA 2275135 A1 · Owner: Icos Corporation · Inventors: Loughney, Kate

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides human PDE8 polypeptides polynucleotides , encoding the polypeptides expression constructs comprising the , polynucleotides host cells transformed with the expression constructs; methods for producing PDE8 polypeptides; antisense polynucleotides; and antibodies specifically immunoreactive with the PDE8 polypeptides.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 16, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 16, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 16, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 16, 1998
GrantedNo grant recorded
Term endedOctober 16, 2018
Patent numberCA 2275135 A1
Classification (IPC)C12N15/55 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedOct 16, 1998Term endedOct 16, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.